S. D. Gillies
- Neurology top 0.5%
- Molecular Biology top 10%
- Oncology top 5%
- Immunology top 5%
- Cancer Research top 5%
- Co-authors
- Alice L. YuR. ReisfeldRalph A. ReisfeldPaul M. SondelJohn M. MarisM. Fevzi ÖzkaynakHiro ShimadaC. Patrick Reynolds
- Topics
- Monoclonal and Polyclonal Antibodies Research (9 papers)Neuroblastoma Research and Treatments (7 papers)Glycosylation and Glycoproteins Research (5 papers)
- Cited by
- NeurologyImmunologyOncology
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesJournal of Clinical Oncology
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
S. D. Gillies
18 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Neurology 1.4k
- Molecular Biology 980
- Oncology 872
- Immunology 702
- Cancer Research 390
Countries citing papers authored by S. D. Gillies
This map shows the geographic impact of S. D. Gillies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. D. Gillies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. D. Gillies more than expected).
Fields of papers citing papers by S. D. Gillies
This network shows the impact of papers produced by S. D. Gillies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. D. Gillies. The network helps show where S. D. Gillies may publish in the future.
Co-authorship network of co-authors of S. D. Gillies
This figure shows the co-authorship network connecting the top 25 collaborators of S. D. Gillies. A scholar is included among the top collaborators of S. D. Gillies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. D. Gillies. S. D. Gillies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 33 | |
| 2 | Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastomabreakdown → | 1233 |
| 3 | 3 | |
| 4 | 11 | |
| 5 | 88 | |
| 6 | 15 | |
| 7 | The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro. | 41 |
| 8 | Construction of phosphorylatable monoclonal antibody CC49 with a casein kinase II recognition site. | 6 |
| 9 | 69 | |
| 10 | 8 | |
| 11 | 185 | |
| 12 | 4 | |
| 13 | 145 | |
| 14 | 25 | |
| 15 | Involvement of B lymphocytes in the growth inhibition of human pulmonary melanoma metastases in athymic nu/nu mice by an antibody-lymphotoxin fusion protein. | 26 |
| 16 | 77 | |
| 17 | 81 | |
| 18 | 167 |
About S. D. Gillies
S. D. Gillies is a scholar working on Radiology, Nuclear Medicine and Imaging, Neurology and Immunology, having authored 18 papers that have together received 2.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Neuroblastoma Research and Treatments (7 papers) and Glycosylation and Glycoproteins Research (5 papers). The work is most often cited by research in Neurology (1.4k citations), Immunology (702 citations) and Oncology (872 citations). S. D. Gillies has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Alice L. Yu, R. Reisfeld, Ralph A. Reisfeld, Paul M. Sondel, John M. Maris, M. Fevzi Özkaynak, Hiro Shimada, C. Patrick Reynolds, Katherine K. Matthay and Helen X. Chen. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.